BACH1, the master regulator gene: A novel candidate target for cancer therapy

被引:93
作者
Davudian, Sadaf [1 ,2 ]
Mansoori, Behzad [1 ]
Shajari, Neda [1 ,2 ]
Mohammadi, Ali [1 ]
Baradaran, Behzad [1 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
关键词
BACH1; Transcription factor; Metastases; Invasion; Regulator; HO-1; KINASE-INHIBITORY-PROTEIN; HEME OXYGENASE-1 GENE; SMALL MAF PROTEINS; BREAST-CANCER; TRANSCRIPTION FACTOR; SIGNALING CASCADE; BONE METASTASES; CLINICAL-COURSE; BTB DOMAIN; IN-VITRO;
D O I
10.1016/j.gene.2016.04.040
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BACH1 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) is a transcriptional factor and a member of cap 'n' collar (CNC) and basic region leucine zipper factor family. In contrast to other bZIP family members, BACH1 appeared as a comparatively specific transcription factor. It acts as transcription regulator and is recognized as a recently hypoxia regulator and functions as an inducible repressor for the HO-1 gene in many human cell types in response to stress oxidative. In regard to studies lately, although, BACH1 has been related to the regulation of oxidative stress and heme oxidation, it has never been linked to invasion and metastasis. Recent studies have showed that BACH1 is involved in bone metastasis of breast cancer by up-regulating vital metastatic genes like CXCR4 and MMP1. This newly discovered aspect of BACH1 gene provides new insight into cancer progression study and stands on its master regulator role in metastasis process, raising the possibility of considering it as a potential target for cancer therapy. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 50 条
  • [41] Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk
    Wang, Yadong
    Yang, Haiyan
    Wang, Haiyu
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 467 - 471
  • [42] Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
    Lu, Renquan
    Sun, Min
    Feng, Jingjing
    Gao, Xiang
    Guo, Lin
    BMC CANCER, 2011, 11
  • [43] Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk
    Yadong Wang
    Haiyan Yang
    Haiyu Wang
    Breast Cancer Research and Treatment, 2015, 150 : 467 - 471
  • [44] Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
    Renquan Lu
    Min Sun
    Jingjing Feng
    Xiang Gao
    Lin Guo
    BMC Cancer, 11
  • [45] LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299
    Huang, Shu-Lin
    Huang, Zhong-Cheng
    Zhang, Chao-Jie
    Xie, Jing
    Lei, Shan-Shan
    Wu, Ya-Qin
    Fan, Pei-Zhi
    BREAST CANCER, 2022, 29 (01) : 65 - 76
  • [46] Amphiregulin as a novel target for breast cancer therapy
    Willmarth, Nicole E.
    Ethier, Stephen P.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2008, 13 (02) : 171 - 179
  • [47] Amphiregulin as a Novel Target for Breast Cancer Therapy
    Nicole E. Willmarth
    Stephen P. Ethier
    Journal of Mammary Gland Biology and Neoplasia, 2008, 13 : 171 - 179
  • [48] MicroRNA as a novel drug target for cancer therapy
    Liu, Xiaoxia
    Liu, Li
    Xu, Qian
    Wu, Ping
    Zuo, Xialin
    Ji, Aimin
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (05) : 573 - 580
  • [49] AXL kinase as a novel target for cancer therapy
    Wu, Xiaoliang
    Liu, Xuewen
    Koul, Sanjay
    Lee, Chang Youl
    Zhang, Zhenfeng
    Halmos, Balazs
    ONCOTARGET, 2014, 5 (20) : 9546 - 9576
  • [50] Cdc42: an effector and regulator of ErbB1 as a strategic target in breast cancer therapy
    Hirsch, Dianne S.
    Wu, Wen Jin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (02) : 147 - 157